Cancer clinical trials in the region Occitanie
319 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Prostate cancer
#NCT06172478
#2023-507641-29-00
Cancer de la prostate résistant à la castration
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo
Phase 2
Lung cancer
#NCT06172478
#2023-507641-29-00
Cancer du poumon
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
1
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT06760819
#2024-517419-62-00
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Ampullary carcinoma
Gastrointestinal stromal tumor
Squamous cell carcinoma
Other
HER2 Positive
Locally Advanced
Metastatic
Metastatic Castration-resistant
HER2
1
Systemic Treatment-Naive
Institut du cancer de Montpellier (Montpellier)
Bayer
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04678362
#2024-516182-37-01
Invasive bladder cancer
Upper excretory tract cancer
Urethral cancer
Urothelial carcinoma
Other
Locally Advanced
Metastatic
None
Chemotherapy
Immunotherapy
Targeted therapy
IUCT Oncopôle (Toulouse)
Centre François Baclesse
Phase 2
Acute leukemia
#NCT05917405
Acute myeloid leukemia (AML)
> 60 ml/min
50-60 ml/min
None
1
Systemic Treatment-Naive
Chemotherapy
IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Hôpital universitaire de Nantes
Phase 2
Acute leukemia
#NCT06191263
Acute myeloid leukemia (AML)
None
Treated / Controled
> 60 ml/min
50-60 ml/min
1
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nîmes (Nîmes)
Ryvu Therapeutics SA
Phase 2
Stomach and esophageal cancer
#NCT06172478
#2023-507641-29-00
Carcinome épidermoïde de l’œsophage
Esophagus
Squamous cell carcinoma
Locally Advanced
Metastatic
2
Chemotherapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT06172478
#2023-507641-29-00
Carcinome urothélial
Invasive bladder cancer
Non-invasive bladder cancer
Upper excretory tract cancer
Urethral cancer
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo
Phase 2
Breast cancer
#NCT06172478
#2023-507641-29-00
Cancer du sein
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
Chemotherapy
Targeted therapy
Hormone therapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo
Phase 2
Pancreas cancer
#NCT06172478
#2023-507641-29-00
Adénocarcinome du pancréas
Adenocarcinoma
Locally Advanced
Metastatic
1
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Daiichi Sankyo